3.1 Subject characteristics
In single-dose trial, 44 subjects
met the selection criteria were received medication to obtain safety
data and were included in the safety analysis set. In the continuous
administration trial, 18 subjects met the selection criteria were
received medication to obtain safety data and were included in the
safety analysis set. Summary demographic information about the 62
subjects who completed the study was summarized in Table1. Healthy,
non-smoking men or women average aged 27.4–30.9 years with a body mass
index of 21.4–23.81 kg/m2 were eligible for inclusion
in the single-dose trial. Healthy, non-smoking men or women average aged
29.7~30.5 years with a body mass index of
22.65-23.30 kg/m2 were eligible for inclusion in the
continuous administration dose.